Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392]

Scritto il 20/03/2026
da Mehrdad Hashemi

No abstract

Biomed Pharmacother. 2026 Mar 19:119216. doi: 10.1016/j.biopha.2026.119216. Online ahead of print.

NO ABSTRACT

PMID:41862345 | DOI:10.1016/j.biopha.2026.119216